Experimental Three-Hormone Drug Produced Major Weight Loss in Trial
In a Lilly-funded phase 2 trial, adults with obesity who received the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks. The results…
In a Lilly-funded phase 2 trial, adults with obesity who received the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks. The results…
Varda Space Industries successfully returned its W-1 mission capsule to Earth, marking the first time a private company has processed pharmaceutical materials in orbit. The mission demonstrated that microgravity can…